Refine by
Drug Development Program Equipment & Supplies Near Usa
6 equipment items found
by:Verb Biotics based inBoston, MASSACHUSETTS (USA)
Yso3 is a preclinical drug development program aimed at treating asthma. Using a revolutionary form of living biotherapy targeting the lung, YSOPIA is pioneering the innovative field of the lung microbiome. As part of this program, YSOPIA has selected a clinical candidate having demonstrated strong in vivo efficacy on ...
Manufactured by:3B Pharmaceuticals GmbH based inBerlin, GERMANY
3B Pharmaceuticals (3BP) is a leading developer of targeted molecular radiopharmaceuticals focusing on cancer indications with high medical need. The focus of our drug development programs is a theragnostic approach using diagnostic imaging to identify patients who are likely responders to radiopharmaceutical therapy. 3BP has ...
by:CrystalsFirst GmbH based inMarburg, GERMANY
X-ray crystallography is a strong method for studying biomolecules’ 3D structure. Data gathering technologies for synchrotron radiation have improved, making this approach even more effective and efficient. The crystal is exposed to an intense stream of X-rays for getting high-resolution structural information. The protein crystals deflect these X-rays, resulting in dispersed beams and a ...
Manufactured by:Firalis Group based inHuningue, FRANCE
As part of the European IMI BT-Cure consortium followed by the H2020 RABIOPRED program launched in 2016, FIRALIS launches its proprietary assay for the identification of markers related to inflammatory-autoimmune ...
Manufactured by:Recursion based inSalt Lake City, UTAH (USA)
Turning drug discovery into a search problem; Central to our mission is the Recursion Operating System (OS), an integrated, multi-faceted system for generating, analyzing and deriving insight from massive biological and chemical datasets to industrialize drug discovery composed ...
Manufactured by:Population Bio, Inc. a Precision Medicine Company based inMelville, NEW YORK (USA)
Population Bio’s patented CNV Beacon® platform is a rapid genetic discovery method that focuses first on identifying disease-relevant copy number variants (CNVs). Once a gene or genomic region is discovered via a CNV, other types of genetic variants – such as single nucleotide variants (SNVs) – can be efficiently revealed to determine the full spectrum of variants that cause ...